Multi-modal Large Language Model-Empowered Talk Therapy for Older Adults With ADRD
SVR
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this study is to test the usefulness and the effect of Smart Virtual Reminiscence (SVR) therapy intervention on the Behavioral and Psychological Symptoms of Dementia (BPSD) of patients with Alzheimer's Disease and Related Dementias (ADRD). SVR is designed to help older adults improve their psychological well-being and cognition. This research supports our long-term goal of designing and implementing intelligent interactive systems to improve the health of individuals with ADRD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 3, 2025
CompletedFirst Submitted
Initial submission to the registry
March 24, 2026
CompletedFirst Posted
Study publicly available on registry
March 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
May 6, 2026
May 1, 2026
1.5 years
March 24, 2026
May 1, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Reduction in BPSD as measured by the Neuropsychiatric Inventory (NPI) total score
Caregivers assess multiple (12) behavior domains for the patient. For each behavior that is present, behavior frequency and severity are rated. Frequency is rated on a 4 point scale, with 1 indicating rare behavior and 4 indicating very frequent behavior. Severity is rated on a 3 point scale, with 1 indicating mild behavior and 3 indicating severe behavior. The product of frequency multiplied by severity equals the total domain score for each behavior. Total domain scores are then summed to obtain the NPI total score. NPI total scores can range from 0 to 144, with higher scores indicating more frequent and severe behaviors overall.
Baseline and Month 3
Rate of all-cause hospitalizations and emergency visits during the study period
These data will be collected and used to assess whether a reduction in BPSD may lead to fewer crisis events requiring acute medical care.
Baseline through study completion, approximately 3 months
Study Arms (2)
Patient Music Therapy
ACTIVE COMPARATORPatient listens to Youtube playlist
Smart Virtual Reminiscence Therapy
EXPERIMENTALPatient uses Smart Virtual Reminiscence Therapy
Interventions
Participants in the attention control group will receive a curated playlist of calming music that they need to listen to twice a week for 12 weeks. The music can be conveniently accessed online (e.g., through YouTube).
SVR Therapy is delivered through a computer program that can be accessed using a personal computer or smart device. It uses virtual reality, automated speech recognition, and large language models to achieve virtual therapist-patient interaction. The SVR therapy platform also automatically sources multi-modal reminiscence materials (e.g., images, text, etc.) through search engines and databases to facilitate the reminiscence therapy sessions. Each participant will participate in two 25-60 min (depending on content) sessions/week across 12 weeks. Each session will include multiple trials of reminiscence, such as music, sports, arts, etc. Each trial takes about 10 minutes to finish. The exact number of trials finished will depend on each patient's speed, preference, and how long they engage in the interaction with the SVR system. The participants can take breaks as needed.
Eligibility Criteria
You may qualify if:
- age ≥ 65 years
- diagnosis of MCI (mild cognitive impairment) or mild ADRD
- access to a reliable internet connection
- community-dwelling
- elevated behavioral and psychological symptoms of dementia (BPSD), indicated by a HABC (Healthy Aging Brain Care) monitor score above 14 on caregiver report or self report (indicating elevated levels of BPSD)
- presence of one or more specific BPSD behaviors (e.g., agitation, anxiety, depression, apathy, or sleep disturbances)
- ability to consent for themselves.
You may not qualify if:
- lives in an assisted living facility or nursing home
- has moderate to severe ADRD as measured by the Quick Dementia Rating System
- has a life expectancy of less than 6 months.
- For the care partner:
- ≥ 21 years old
- self-identified care partner (e.g., is knowledgeable about the patient's daytime and nighttime behaviors) of a community-dwelling patient diagnosed with MCI or mild ADRD who will also participate in the study
- has MCI or dementia
- has a severe mental illness or substance abuse
- has a life expectancy of less than 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sidney & Lois Eskenazi Hospital
Indianapolis, Indiana, 46202, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Malaz Boustani, MD, MPH
Indiana University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 24, 2026
First Posted
March 30, 2026
Study Start
September 3, 2025
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
May 6, 2026
Record last verified: 2026-05